您当前的位置:
首页 >
文章列表页 >
Sishenwan Ameliorates Visceral Sensitivity in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome (Spleen-kidney Yang Deficiency) by Regulating p38 MAPK/JNK/TRPV1 Pathway
更新时间:2024-10-09
    • Sishenwan Ameliorates Visceral Sensitivity in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome (Spleen-kidney Yang Deficiency) by Regulating p38 MAPK/JNK/TRPV1 Pathway

    • The latest research has found that Sishen Wan can effectively improve visceral sensitivity in diarrhea predominant irritable bowel syndrome rats with spleen kidney yang deficiency, possibly by regulating the p38 MAPK/JNK/TRPV1 signaling pathway.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 21, Pages: 10-18(2024)
    • DOI:10.13422/j.cnki.syfjx.20241207    

      CLC: R2-0;R22;R285.5;R289;R33
    • Received:14 June 2024

      Published Online:28 August 2024

      Published:05 November 2024

    移动端阅览

  • LI Siqi,HU Yunlian,SU Chengxia,et al.Sishenwan Ameliorates Visceral Sensitivity in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome (Spleen-kidney Yang Deficiency) by Regulating p38 MAPK/JNK/TRPV1 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):10-18. DOI: 10.13422/j.cnki.syfjx.20241207.

  •  
  •  

0

Views

121

下载量

3

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Sishenwan Restores Intestinal Barrier in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome Due to Spleen-kidney Yang Deficiency by Regulating Intestinal Flora and Short-chain Fatty Acids
Clinical Application and Pharmacological Mechanism of Sishenwan in Treatment of Ulcerative Colitis: A Review
Traditional Chinese Medicine Intervention in Diarrhea-predominant Irritable Bowel Syndrome Based on Gut-brain Axis: A Review
Mechanism of Intervening with Diarrhea-predominant Irritable Bowel Syndrome in Rats with Spleen Deficiency by Xingpi Capsules Through Regulating 5-HT-RhoA/ROCK2 Pathway

Related Author

ZHANG Qian
LI Siqi
HUYunlian
WEN Na
HUANG Chaoqun
LIU Binbin
SU Chengxia
ZHANG Qian

Related Institution

College of Traditional Chinese Medicine,Hubei University of Chinese Medicine
The First Clinical Medical College,Hubei University of Chinese Medicine
Hubei Provincial Hospital of Traditional Chinese Medicine/Affiliated Hospital of Hubei University of Chinese Medicine
The First Clinical Medical College,Hubei University of Chinese Medicine,Wuhan 43006l
Hubei Provincial Hospital of Traditional Chinese Medicine/Affiliated Hospital of Hubei University of Chinese Medicine,Wuhan 43006l
0